Why GLP-1 Support Is Not The Same As GLP-1 Medication Supporting metabolic health through nutrition is not the same as altering hormone signaling
Suitable for men and women seeking to safely and effectively manage their weight and improve their overall health
Side effects tracker Some medications cause initial side effects that will resolve on their own, while others can cause persistent side effects that require medical attention

These are the main differences between the different types of GLP-1 agonists: Semaglutide (Ozempic, Wegovy) Strong anti-inflammatory potential Powerful metabolic benefits and weight loss Longer duration, but higher risk of GI and vestibular side effects Only works on immune cells receptors( not on adipose tissue directly) Tirzepatide (Mounjaro, Zepbound) Works on both GLP-1 and GIP receptors (targeting adipose tissue receptors) Strong anti-inflammatory and insulin-sensitivity effects Significant weight loss Higher likelihood of GI issues in some women Liraglutide (Saxenda) Daily injection Lowest weight loss and inflammation benefits Often gentler on the gut Poorer response for Lipedema in later stages The best choice often depends on: Your gut health Whether you struggle with dizziness or vestibular issues Your appetite levels Your sensitivity to medications Your nutrition status For Lipedema patients, Tirzepatide remains the best therapeutic choice to have a significant benefit on the adipose tissue

In a statement to TODAY.com, Novo Nordisk, which makes both Ozempic and Wegovy, says it doesnt have clinical data evaluating the effect of the drugs on fertility treatments
Slimming, glowing and whitening coffee in one sachet